Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients

Update Il y a 4 ans
Reference: NCT01632358

Woman and Man

Extract

The study will assess the safety, tolerability and pharmacokinetics of TAP311 in patients with dyslipidemia.


Inclusion criteria

  • Dyslipidaemia

Links